About US
Contact us
-
SFDA Deputy Commissioner Bian Zhenjia meets Director General of Social Work Department of LOCPG and President of the Hong Kong Federation of Trade UnionsOn July 11, 2011, Bian Zhenjia, Deputy Commissioner of the State Food and Drug Administration (SFDA), met with the visiting Mr. Zhang Tiefu, Director General of Social Work Department of the Liaison O2011/7/14
-
SAS expands Global Certification Program offeringsSAS, the leader in business analytics software and services and the de facto industry standard for clinical data analysis and reporting in the life sciences/pharmaceutical industry, today expanded its2011/7/14
-
New approach for producing human-derived gelatinScientists are reporting development of a new approach for producing large quantities of human-derived gelatin that could become a substitute for some of the 300,000 tons of animal-based gelatin produ2011/7/14
-
BRICS health ministers agree to improve access to low-cost medicinesHealth ministers from Brazil, Russia, India, China, and South Africa in Beijing "on Monday vowed to improve access to low-cost and high-quality medicine - and called on developed nations to shoulder r2011/7/13
-
Gilead Joins Medicines Patent PoolGilead Sciences has signed up to the Medicines Patent Pool to improve access to HIV treatments in developing countries, becoming the first pharmaceutical firm to do so. Founded in 2010, the Medici2011/7/13
-
SFDA makes stage achievements in the special operation against IPR infringement and counterfeitingIn order to ensure drug safety for the public, aiming at the current characteristics of the production and distribution of counterfeit drugs, The State Food and Drug Administration (SFDA) cracks down2011/7/12
-
SFDA issues the Second Summary of Announcements of Illegal Drug, Medical Device, and Health Food Advertisements in 2011On June 30, 2011, the State Food and Drug Administration (SFDA) issued the Second Summary of Announcements of Illegal Drug, Medical Device, and Health Food Advertisements in 2011.2011/7/12
-
Bayer Hit With Landmark Social Media CaseBayer Healthcare has been found to have breached the UK pharmaceutical industry's code of conduct after promoting prescription-only medicines on social networking site Twitter. The company was fou2011/7/12
-
GlaxoSmithKline's Boostrix receives FDA approval to prevent tetanus, diphtheria, and pertussisThe U.S. Food and Drug Administration today approved Boostrix vaccine to prevent tetanus, diphtheria, and pertussis (whooping cough) in people ages 65 and older. Currently, there are vaccines approv2011/7/11
-
APP receives FDA approval to market Clonidine Hydrochloride InjectionAPP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to2011/7/11